![](/images/general/no_picture/200_user.png)
Margaret G Moore
Examiner (ID: 1525, Phone: (571)272-1090 , Office: P/1765 )
Most Active Art Unit | 1712 |
Art Unit(s) | 1712, 1765, 1501, 1796 |
Total Applications | 3275 |
Issued Applications | 2210 |
Pending Applications | 287 |
Abandoned Applications | 778 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7005151
[patent_doc_number] => 20050170464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Prokaryotically produced antibodies and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/071291
[patent_app_country] => US
[patent_app_date] => 2005-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 28033
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20050170464.pdf
[firstpage_image] =>[orig_patent_app_number] => 11071291
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/071291 | Prokaryotically produced antibodies and use thereof | Mar 1, 2005 | Abandoned |
Array
(
[id] => 7045512
[patent_doc_number] => 20050250107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Selectable gene marker system based on expression of N-acetyllactosaminide 3-alpha galactosyltransferase'
[patent_app_type] => utility
[patent_app_number] => 10/838750
[patent_app_country] => US
[patent_app_date] => 2004-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12412
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250107.pdf
[firstpage_image] =>[orig_patent_app_number] => 10838750
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/838750 | Selectable gene marker system based on expression of N-acetyllactosaminide 3-α galactosyltransferase | May 3, 2004 | Issued |
Array
(
[id] => 7061041
[patent_doc_number] => 20050003402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Novel isoforms of centromere protein E (CENPE)'
[patent_app_type] => utility
[patent_app_number] => 10/828985
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17537
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003402.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828985
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828985 | Novel isoforms of centromere protein E (CENPE) | Apr 20, 2004 | Abandoned |
Array
(
[id] => 7323631
[patent_doc_number] => 20040137486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Method and system for testing and characterizing food products'
[patent_app_type] => new
[patent_app_number] => 10/722105
[patent_app_country] => US
[patent_app_date] => 2003-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13046
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20040137486.pdf
[firstpage_image] =>[orig_patent_app_number] => 10722105
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/722105 | Method and system for testing and characterizing food products | Nov 24, 2003 | Abandoned |
Array
(
[id] => 7258004
[patent_doc_number] => 20040260060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Constructs modified downstreams of the initiation codon for recombinant protein'
[patent_app_type] => new
[patent_app_number] => 10/311976
[patent_app_country] => US
[patent_app_date] => 2003-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7225
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20040260060.pdf
[firstpage_image] =>[orig_patent_app_number] => 10311976
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/311976 | Constructs modified downstreams of the initiation codon for recombinant protein | Nov 18, 2003 | Abandoned |
Array
(
[id] => 7166642
[patent_doc_number] => 20040077038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Methods for production of proteins in host cells'
[patent_app_type] => new
[patent_app_number] => 10/714212
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6519
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077038.pdf
[firstpage_image] =>[orig_patent_app_number] => 10714212
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/714212 | Methods for production of proteins in host cells | Nov 12, 2003 | Abandoned |
Array
(
[id] => 7449491
[patent_doc_number] => 20040067552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Adipocyte complement related protein zacrp14'
[patent_app_type] => new
[patent_app_number] => 10/423584
[patent_app_country] => US
[patent_app_date] => 2003-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 47444
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20040067552.pdf
[firstpage_image] =>[orig_patent_app_number] => 10423584
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/423584 | Adipocyte complement related protein zacrp14 | Apr 24, 2003 | Abandoned |
Array
(
[id] => 7403204
[patent_doc_number] => 20040023855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Biologic modulations with nanoparticles'
[patent_app_type] => new
[patent_app_number] => 10/409786
[patent_app_country] => US
[patent_app_date] => 2003-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 27197
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023855.pdf
[firstpage_image] =>[orig_patent_app_number] => 10409786
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/409786 | Biologic modulations with nanoparticles | Apr 7, 2003 | Abandoned |
Array
(
[id] => 6740314
[patent_doc_number] => 20030157683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Antibodies for apoptosis EI24 protein and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/385450
[patent_app_country] => US
[patent_app_date] => 2003-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19674
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157683.pdf
[firstpage_image] =>[orig_patent_app_number] => 10385450
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/385450 | Antibodies for apoptosis EI24 protein and methods of use | Mar 11, 2003 | Issued |
Array
(
[id] => 7474207
[patent_doc_number] => 20040097453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Method for treatment of cancer and infectious diseases and compositions useful in same'
[patent_app_type] => new
[patent_app_number] => 10/386994
[patent_app_country] => US
[patent_app_date] => 2003-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5183
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097453.pdf
[firstpage_image] =>[orig_patent_app_number] => 10386994
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/386994 | Method for treatment of cancer and infectious diseases and compositions useful in same | Mar 10, 2003 | Abandoned |
Array
(
[id] => 6706252
[patent_doc_number] => 20030152986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Method for sorting antifungal molecules acting on the glucanosyltransferase activity'
[patent_app_type] => new
[patent_app_number] => 10/347252
[patent_app_country] => US
[patent_app_date] => 2003-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9416
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20030152986.pdf
[firstpage_image] =>[orig_patent_app_number] => 10347252
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/347252 | Method for sorting antifungal molecules acting on the glucanosyltransferase activity | Jan 20, 2003 | Issued |
Array
(
[id] => 6842509
[patent_doc_number] => 20030147856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Method for sorting antifungal molecules acting on the glucanosyltransferase activity'
[patent_app_type] => new
[patent_app_number] => 10/347278
[patent_app_country] => US
[patent_app_date] => 2003-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9381
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20030147856.pdf
[firstpage_image] =>[orig_patent_app_number] => 10347278
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/347278 | Method for sorting antifungal molecules acting on the glucanosyltransferase activity | Jan 20, 2003 | Issued |
Array
(
[id] => 7365427
[patent_doc_number] => 20040005709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Hybridization control of sequence variation'
[patent_app_type] => new
[patent_app_number] => 10/279633
[patent_app_country] => US
[patent_app_date] => 2002-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 59211
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20040005709.pdf
[firstpage_image] =>[orig_patent_app_number] => 10279633
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/279633 | Hybridization control of sequence variation | Oct 23, 2002 | Abandoned |
Array
(
[id] => 7312756
[patent_doc_number] => 20040033481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Method for identifying validated target and assay combinations for drug development'
[patent_app_type] => new
[patent_app_number] => 10/278768
[patent_app_country] => US
[patent_app_date] => 2002-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 23899
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20040033481.pdf
[firstpage_image] =>[orig_patent_app_number] => 10278768
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/278768 | Method for identifying validated target and assay combinations for drug development | Oct 21, 2002 | Abandoned |
Array
(
[id] => 6765667
[patent_doc_number] => 20030100067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Use of the nucleotide sequence of the promoter of the lactose operon of Lactobacillus casei to regulate the genic expression through an anti-terminator protein'
[patent_app_type] => new
[patent_app_number] => 10/266080
[patent_app_country] => US
[patent_app_date] => 2002-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5616
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20030100067.pdf
[firstpage_image] =>[orig_patent_app_number] => 10266080
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/266080 | Use of the nucleotide sequence of the promoter of the lactose operon of Lactobacillus casei to regulate the genic expression through an anti-terminator protein | Oct 6, 2002 | Abandoned |
Array
(
[id] => 6696338
[patent_doc_number] => 20030108532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Methods for identifying peptide aptamers capable of altering a cell phenotype'
[patent_app_type] => new
[patent_app_number] => 10/263577
[patent_app_country] => US
[patent_app_date] => 2002-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10687
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20030108532.pdf
[firstpage_image] =>[orig_patent_app_number] => 10263577
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/263577 | Methods for identifying peptide aptamers capable of altering a cell phenotype | Oct 2, 2002 | Abandoned |
Array
(
[id] => 6683327
[patent_doc_number] => 20030119191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Compositions and methods for helper-free production of recombinant adeno-associated viruses'
[patent_app_type] => new
[patent_app_number] => 10/251157
[patent_app_country] => US
[patent_app_date] => 2002-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13141
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119191.pdf
[firstpage_image] =>[orig_patent_app_number] => 10251157
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/251157 | Compositions and methods for helper-free production of recombinant adeno-associated viruses | Sep 19, 2002 | Issued |
Array
(
[id] => 6651338
[patent_doc_number] => 20030105055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Methods and compositions for the treatment of ocular diseases'
[patent_app_type] => new
[patent_app_number] => 10/247136
[patent_app_country] => US
[patent_app_date] => 2002-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8710
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20030105055.pdf
[firstpage_image] =>[orig_patent_app_number] => 10247136
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/247136 | Methods and compositions for the treatment of ocular diseases | Sep 17, 2002 | Abandoned |
Array
(
[id] => 6529234
[patent_doc_number] => 20020192825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Methods of use of viral vectors to deliver antigen to dendritic cells'
[patent_app_type] => new
[patent_app_number] => 10/193935
[patent_app_country] => US
[patent_app_date] => 2002-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15931
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20020192825.pdf
[firstpage_image] =>[orig_patent_app_number] => 10193935
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/193935 | Methods of use of viral vectors to deliver antigen to dendritic cells | Jul 10, 2002 | Abandoned |
Array
(
[id] => 6869825
[patent_doc_number] => 20030082514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Method for identification of biologically active peptides and nucleic acids'
[patent_app_type] => new
[patent_app_number] => 10/178045
[patent_app_country] => US
[patent_app_date] => 2002-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4735
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 282
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082514.pdf
[firstpage_image] =>[orig_patent_app_number] => 10178045
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/178045 | Method for identification of biologically active peptides and nucleic acids | Jun 19, 2002 | Abandoned |